Darlene Noci - 29 Jun 2026 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Reporting relationship: Chief Development Officer
Issuer ticker: NUVL
Reported as of: 29 Jun 2026
Net transaction value: -$679,305
SEC form: 4
Accepted by SEC: 01 Jul 2026, 16:30:34 UTC
Prior SEC filing: 11 Jun 2026
Next SEC filing: 06 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Nathan McConarty, attorney-in-fact

Key filing fact

Darlene Noci filed Form 4 for Nuvalent, Inc. (NUVL) on 01 Jul 2026.

Key facts

This page summarizes Darlene Noci's Form 4 filing for Nuvalent, Inc. (NUVL).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 01 Jul 2026, 16:30.

Change

Previous filing in this sequence was filed on 11 Jun 2026.
Current net transaction value: -$679,305.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001862148 Primary reporting owner

Noci Darlene

Relationship: Chief Development Officer
Address: C/O NUVALENT, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Signature: /s/ Nathan McConarty, attorney-in-fact
Signature date: 01 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUVL transaction

Class A Common Stock

Options Exercise

Transaction value
Shares: +5,500
Change %: +9.5%
Price: $27.85^*
Shares after: 63,617
Date: 29 Jun 2026
Ownership: Direct
Footnotes: F1

NUVL transaction

Class A Common Stock

Sale

Transaction value: $679,305
Shares: -5,500
Change %: -8.6%
Price: $123.51
Shares after: 58,117
Date: 29 Jun 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUVL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -5,500
Change %: -6.3%
Price: $0.000000^*
Shares after: 81,329
Date: 29 Jun 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 5,500
Exercise price: $27.85
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.

Footnote F2

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.47 to $123.56, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.

Footnote F3

The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.